Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire

…, RL Spitzer, JR Calabrese… - American journal of …, 2000 - Am Psychiatric Assoc
OBJECTIVE: Bipolar spectrum disorders, which include bipolar I, bipolar II, and bipolar disorder
not otherwise specified, frequently go unrecognized, undiagnosed, and untreated. This …

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients …

…, S Kanba, B Lafer, T Suppes, JR Calabrese… - Bipolar …, 2018 - Wiley Online Library
The Canadian Network for Mood and Anxiety Treatments ( CANMAT ) previously published
treatment guidelines for bipolar disorder in 2005, along with international commentaries and …

Efficacy of divalproex vs lithium and placebo in the treatment of mania

CL Bowden, AM Brugger, AC Swann, JR Calabrese… - Jama, 1994 - jamanetwork.com
Objective. —To compare the effectiveness of divalproex sodium with that of lithium and placebo
in patients with acute mania. Design. —Randomized, double-blind, parallel-group study …

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression

JR Calabrese, CL Bowden, GS Sachs… - Journal of Clinical …, 1999 - psychiatrist.com
Background: More treatment options for bipolar depression are needed. Currently available
antidepressants may increase the risk of mania and rapid cycling, and mood stabilizers …

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

JR Calabrese, PE Keck Jr… - American Journal of …, 2005 - Am Psychiatric Assoc
OBJECTIVE: There is a major unmet need for effective options in the treatment of bipolar
depression. METHOD: Five hundred forty-two outpatients with bipolar I (N=360) or II (N=182) …

[HTML][HTML] Effectiveness of adjunctive antidepressant treatment for bipolar depression

GS Sachs, AA Nierenberg, JR Calabrese… - … England Journal of …, 2007 - Mass Medical Soc
Background Episodes of depression are the most frequent cause of disability among patients
with bipolar disorder. The effectiveness and safety of standard antidepressant agents for …

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder

CL Bowden, JR Calabrese, SL McElroy… - Archives of general …, 2000 - jamanetwork.com
Background Long-term outcomes are often poor in patients with bipolar disorder despite
treatment; more effective treatments are needed to reduce recurrences and morbidity. This …

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

CL Bowden, JR Calabrese, G Sachs… - Archives of general …, 2003 - jamanetwork.com
Background Lamotrigine has been shown to be an effective treatment for bipolar
depression and rapid cycling in placebo-controlled clinical trials. This double-blind, placebo-controlled …

Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease

…, A Roy, MA Kling, JR Calabrese… - … England Journal of …, 1986 - Mass Medical Soc
Primary depression can be associated with substantial hypercortisolism, thus prompting some
researchers to suggest that depression shares pathophysiologic features with Cushing's …

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder

JR Calabrese, CL Bowden, G Sachs… - Journal of Clinical …, 2003 - psychiatrist.com
Background: The anticonvulsant lamotrigine was previously shown to be effective for bipolar
depression. This study assessed the efficacy and tolerability of lamotrigine and lithium …